Vitamin D receptor FokI polymorphism and the risks of colorectal cancer, inflammatory bowel disease, and colorectal adenoma

[1]  J. Oh,et al.  Dietary Flavonoids, CYP1A1 Genetic Variants, and the Risk of Colorectal Cancer in a Korean population , 2017, Scientific Reports.

[2]  Da-guan Zhang,et al.  The association between vitamin D receptor polymorphisms and serum 25-hydroxyvitamin D levels with ulcerative colitis in Chinese Han population. , 2017, Clinics and research in hepatology and gastroenterology.

[3]  R. Halwani,et al.  Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population , 2016, PloS one.

[4]  Ahmad Esmaillzadeh,et al.  Vitamin D status in relation to Crohn's disease: Meta-analysis of observational studies. , 2016, Nutrition.

[5]  C. Appleyard,et al.  Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease. , 2016, World journal of gastroenterology.

[6]  Da-guan Zhang,et al.  Association of vitamin D receptor gene polymorphisms and serum 25‐hydroxyvitamin D levels with Crohn's disease in Chinese patients , 2016, Journal of gastroenterology and hepatology.

[7]  M. Veysey,et al.  Vitamin D Receptor Polymorphisms Relate to Risk of Adenomatous Polyps in a Sex-Specific Manner , 2016, Nutrition and cancer.

[8]  D. Hu,et al.  Association of vitamin D receptor gene polymorphisms with the susceptibility to ulcerative colitis in patients from Southeast China , 2015, Journal of receptor and signal transduction research.

[9]  J. E. Lee,et al.  Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis. , 2015, World journal of gastroenterology.

[10]  C. Appleyard,et al.  Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. , 2015, World journal of gastroenterology.

[11]  E. Giovannucci,et al.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status , 2015, Gut.

[12]  A. Milewicz,et al.  Vitamin D receptor gene polymorphisms in relation to the risk of colorectal cancer in the Polish population , 2014, Tumor Biology.

[13]  S. Gandini,et al.  Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis. , 2014, Carcinogenesis.

[14]  J. Vadgama,et al.  Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants , 2014, Cancer.

[15]  J. Zhong,et al.  Polymorphisms of the vitamin D receptor gene and the risk of inflammatory bowel disease: a meta-analysis. , 2014, Genetics and molecular research : GMR.

[16]  D. Bikle,et al.  Vitamin D metabolism, mechanism of action, and clinical applications. , 2014, Chemistry & biology.

[17]  A. Ananthakrishnan,et al.  Review article: vitamin D and inflammatory bowel diseases , 2014, Alimentary pharmacology & therapeutics.

[18]  A. Sameer,et al.  Association of a VDR gene polymorphism with risk of colorectal cancer in Kashmir. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[19]  Peter Szolovits,et al.  Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  E. Giovannucci.  Epidemiology of vitamin D and colorectal cancer. , 2012, Anti-cancer agents in medicinal chemistry.

[21]  R. W. Bentley,et al.  Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study. , 2012, The New Zealand medical journal.

[22]  E. Giovannucci,et al.  Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. , 2012, Gastroenterology.

[23]  Teruhiko Yoshida,et al.  Association between plasma 25-hydroxyvitamin D and colorectal adenoma according to dietary calcium intake and vitamin D receptor polymorphism. , 2012, American journal of epidemiology.

[24]  M. Zali,et al.  Start codon FokI and intron 8 BsmI variants in the vitamin D receptor gene and susceptibility to colorectal cancer , 2011, Molecular Biology Reports.

[25]  C. O'Morain,et al.  Common variation in the vitamin D receptor gene and risk of inflammatory bowel disease in an Irish case–control study , 2011, European journal of gastroenterology & hepatology.

[26]  Li Xia Zhao,et al.  Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese , 2011, Journal of digestive diseases.

[27]  F. Clavel-Chapelon,et al.  Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  Z. Motahari,et al.  Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease , 2008, Journal of gastroenterology and hepatology.

[29]  A. Tenesa,et al.  Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding , 2008, International journal of cancer.

[30]  R. Elston,et al.  Association of vitamin D receptor gene variants, adiposity and colon cancer. , 2008, Carcinogenesis.

[31]  F. Lammert,et al.  Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes , 2008, International Journal of Colorectal Disease.

[32]  John P. A. Ioannidis,et al.  Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls , 2008, Human Genetics.

[33]  F. Schmidt.  Meta-Analysis , 2008 .

[34]  Karen Coats,et al.  Huge (review) , 2007 .

[35]  I. Roots,et al.  Vitamin D receptor haplotypes protect against development of colorectal cancer , 2007, European Journal of Clinical Pharmacology.

[36]  K. Badenhoop,et al.  The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system , 2007, European journal of immunology.

[37]  R. Wolff,et al.  Vitamin D Receptor Gene Polymorphisms, Dietary Promotion of Insulin Resistance, and Colon and Rectal Cancer , 2006, Nutrition and cancer.

[38]  J. Nam,et al.  Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. , 2006, Cancer letters.

[39]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. , 2005, American journal of epidemiology.

[40]  A. Uitterlinden,et al.  Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.

[41]  S. Ingles,et al.  Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. , 2003, Carcinogenesis.

[42]  H. DeLuca,et al.  Where is the vitamin D receptor? , 2002, Archives of biochemistry and biophysics.

[43]  R. Sinha,et al.  Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  S. Kato,et al.  Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. , 2001, Carcinogenesis.

[45]  C. Ulrich,et al.  Vitamin D Receptor Polymorphism and the Risk of Colorectal Adenomas , 2001 .

[46]  G. Coetzee,et al.  Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States) , 2001, Cancer Causes & Control.

[47]  D. Jewell,et al.  Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility , 2000, Gut.

[48]  M. Jäättelä,et al.  Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. , 1999, Cancer research.

[49]  H. Yamamoto,et al.  Structural organization of the human vitamin D receptor chromosomal gene and its promoter. , 1997, Molecular endocrinology.

[50]  D. Podolsky.  Inflammatory bowel disease (Second of two parts) , 1991 .

[51]  D. Ahlquist,et al.  Colorectal Adenomas. , 2016, The New England journal of medicine.

[52]  Y. Maehara,et al.  Associations between vitamin D receptor (VDR) gene polymorphisms and colorectal cancer risk and effect modifications of dietary calcium and vitamin D in a Japanese population. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[53]  D. Greenwood,et al.  Meta-analysis of Observational Studies , 2012 .

[54]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[55]  Juan Carlos Espinosa,et al.  Comprehensive Meta-Analysis , 2004 .